Syngene International Ltd share price logo

Syngene Intl Share Price

NSE: SYNGENE

BSE: 539268

Small Cap

Healthcare Sector

₹655.55

+0.90

(+0.14%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Syngene Intl Stock Performance

as on December 29, 2025 at 4:01 pm IST

  • Day's Low

    Day's High

    ₹651.3
    ₹659.45
    downward going graph

    0.65%

    Downside

    0.59%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹599.55
    ₹895.75
    downward going graph

    8.54%

    Downside

    36.64%

    Upside

    downward going graph

Syngene Intl share price movements today

Previous Close
₹654.65
Open
₹657.90
Volume
4.95L
Upper Circuit
₹720.10
Lower Circuit
₹589.20
Day's Low - High
₹651.3 - ₹659.45
52 Week Low - High
₹599.55 - ₹895.75

Syngene Intl Historical Returns

1 Month Return
+ 1.43 %
3 Month Return
+ 6.57 %
1 Year Return
-23.78 %
3 Year Return
+ 13.36 %
5 Year Return
+ 9.33 %

Syngene Intl Fundamentals

as on December 29, 2025 at 4:01 pm IST

Market Cap

₹26,378.43 Cr

Return on Equity (ROE)

10.6

PE Ratio (TTM)

56.14

Return on capital employed (ROCE)

13.04

Industry PE ratio

49.42

Beta (LTM)

0.92

P/B Ratio

6.3

Dividend Yield

0.17

PEG Ratio

-160.41

Quarterly Earnings Growth YOY

-36.76

EPS (TTM)

12.33

Sector

Healthcare

Book Value

117.44

Technical Analysis

Bullish

View Technical Analysis

Syngene Intl Stock Valuation

as on December 29, 2025 at 4:01 pm IST

Syngene Intl in the last 5 years

  • Overview

  • Trends

Lowest (23.09x)

March 31, 2020

Industry (49.42x)

December 26, 2025

Today (56.14x)

December 26, 2025

Highest (78.92x)

December 2, 2024

LowHigh

Today’s Price to Earnings Ratio: 56.14x

Syngene International Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Syngene Intl with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Syngene International Ltd image
Syngene International Ltd
BUY26,378.431.87%0.584963,642
Sanofi India Ltd image
Sanofi India Ltd
BUY9,431.48-10.08%0.524132,013
Aurobindo Pharma Ltd image
Aurobindo Pharma Ltd
BUY70,056.296.65%0.603,48331,723
Zydus Lifesciences Ltd image
Zydus Lifesciences Ltd
HOLD91,723.2618.03%0.614,61423,241
Abbott India Ltd image
Abbott India Ltd
BUY61,423.1316.82%0.001,4146,445
See all

Analyst Recommendation on Syngene Intl Stock

Based on 8 analysts

BUY

62.50%

Buy

12.50%

Hold

25.00%

Sell

Based on 8 analysts, 62.5% of analysts recommend a 'BUY' rating for Syngene Intl . Average target price of ₹715

Source: S&P Global Market Intelligence

Syngene Intl Share Price Target

Get share price movements and forecasts by analysts on Syngene Intl .

What analysts predicted

9.22%UPSIDE

Target Price

₹715

Current Price

₹655.55

Analyzed by

8 Analysts

High

₹835

Target

₹715.00

Low

₹550

Syngene Intl target price ₹715, a slight upside of 9.22% compared to current price of ₹655.55. According to 8 analysts rating.

Source: S&P Global Market Intelligence

Syngene Intl Stock’s Investor Sentiment and Interest

Search interest for Syngene International Ltd Stock has increased by 6% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:6% versus previous 30 day period

Syngene International Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Sales
785.9
994.4
808.1
910.1
853.5
916.9
789.7
891
943.7
1,018
874.5
910.6
Other Income
17.2
22.8
23.6
21.6
29.3
16.1
50.1
16.5
18.3
18.9
17.7
15.4
Total Income
803.1
1,017.2
831.7
931.7
882.8
933
839.8
907.5
962
1,036.9
892.2
926
Expenses
554.9
680.3
596.2
663.4
625.7
600
619.9
646.2
660.1
674.4
668.1
711.1
Operating Profit
231
314.1
211.9
246.7
227.8
316.9
169.8
244.8
283.6
343.6
206.4
199.5
Operating Profit Margin %
29.39%
31.59%
26.22%
27.11%
26.69%
34.56%
21.5%
27.47%
30.05%
33.75%
23.6%
21.91%
Profit Before Interest, Tax and Depreciation
248.2
336.9
235.5
268.3
257.1
333
219.9
261.3
301.9
362.5
224.1
214.9
Interest
13.7
10.4
10.5
13
10.8
12.9
11.7
13.1
12.4
15.9
11.6
13.2
Depreciation
94.6
95.6
102.1
104.6
108.1
111.1
106.9
110.9
108.7
106.1
111.2
116.5
Profit Before Tax
139.9
230.9
122.9
150.7
138.2
209
101.3
137.3
180.8
240.5
101.3
85.2
Tax Paid
30.2
52.2
29.5
34.2
26.7
20.4
25.6
31.2
49.7
57.2
14.6
18.1
Profit After Tax
109.7
178.7
93.4
116.5
111.5
188.6
75.7
106.1
131.1
183.3
86.7
67.1
Total Net profit including share of profit / Loss from associate company
109.7
178.7
93.4
116.5
111.5
188.6
75.7
106.1
131.1
183.3
86.7
67.1
EPS
2.74
4.36
2.33
2.9
2.78
4.7
1.89
2.64
3.27
4.56
2.16
1.67
Actual EPS
2.74
4.36
2.33
2.9
2.78
4.7
1.89
2.64
3.27
4.56
2.16
1.67
Adjusted EPS
2.74
4.36
2.33
2.9
2.78
4.7
1.89
2.64
3.27
4.56
2.16
1.67
Diluted EPS
2.71
4.43
2.32
2.9
2.77
4.69
1.88
2.64
3.26
4.56
2.16
1.67

Syngene International Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
1,423.1
1,825.6
2,011.9
2,184.3
2,604.2
3,192.9
3,488.6
3,642.4
Other Income
61.8
75.1
152.9
99.6
52.8
70.9
90.6
103.8
Total Income
1,484.9
1,900.7
2,164.8
2,283.9
2,657
3,263.8
3,579.2
3,746.2
Expenses
958.3
1,288.8
1,394
1,512.5
1,838.8
2,258.5
2,485.3
2,600.6
Operating Profit
464.8
536.8
617.9
671.8
765.4
934.4
1,003.3
1,041.8
Operating Profit Margin %
32.66%
29.4%
30.71%
30.76%
29.39%
29.26%
28.76%
28.6%
Profit Before Interest, Tax and Depreciation
526.6
611.9
770.8
771.4
818.2
1,005.3
1,093.9
1,145.6
Interest
22.7
32.3
34.6
27.7
24.1
45.2
47.2
53.1
Depreciation
131.4
164.2
219.3
274.5
309.7
366.5
425.9
432.6
Profit Before Tax
372.5
415.4
516.9
469.2
484.4
593.6
620.8
659.9
Tax Paid
67.1
83.8
104.8
64.3
88.6
129.2
110.8
163.7
Profit After Tax
305.4
331.6
412.1
404.9
395.8
464.4
510
496.2
Total Net profit including share of profit / Loss from associate company
305.4
331.6
412.1
404.9
395.8
464.4
510
496.2
EPS
15.47
8.39
10.38
10.18
9.94
11.59
12.71
12.35
Actual EPS
15.47
8.39
10.38
10.18
9.94
11.59
12.71
12.35
Adjusted EPS
7.74
4.2
10.38
10.18
9.94
11.59
12.71
12.35
Diluted EPS
15.43
8.36
10.35
10.11
9.82
11.51
12.69
12.34

Syngene International Ltd Cash Flow

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
446.2
630.4
677.1
701.2
580.6
823.5
1,042.1
1,167.6
Cash Flow from Investing Activities
-349.3
-645.5
-423.8
-628.9
-610.8
-653.3
-494.5
-744.4
Cash Flow from Financing Activities
-78.7
-72.4
-225.5
58
-31.3
-342.5
-551.4
-141.8
Net Cash Flow
18.2
-87.5
27.8
130.3
-61.5
-172.3
-3.8
281.4

Syngene Intl Stock Shareholding Pattern

Numbers in percentages

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Promoters
54.88%
54.8%
54.79%
54.79%
54.79%
54.72%
54.72%
52.74%
52.74%
52.68%
52.68%
DII
10.73%
11.2%
9.94%
13.08%
15.8%
16.8%
17.48%
19.53%
21.5%
24.05%
24.62%
FII
0.02%
0%
0%
0%
20.92%
20.63%
20.72%
20.64%
19.47%
16.5%
16.31%
Public
10.63%
10.21%
9.46%
9.05%
8.17%
7.42%
6.74%
6.8%
6%
6.45%
6.08%
Total Outstanding Shares
40,14,34,500
40,20,15,000
40,20,15,000
40,20,15,000
40,20,15,000
40,25,36,981
40,25,36,981
40,25,36,981
40,25,36,981
40,29,39,420
40,29,39,420
Total Shareholders
1,24,014
1,25,455
1,25,992
1,21,880
1,15,850
1,20,018
1,07,338
1,28,806
1,25,090
1,42,310
1,36,061

Mutual Funds that own Syngene Intl Stock

Check out the Mutual Funds with significant holdings in Syngene Intl .

Syngene Intl Corporate Actions

View detailed summary of the earnings and dividend history of Syngene Intl .

  • Syngene International Ltd Earnings Results

    Syngene International Ltd’s net profit fell -36.76% since last year same period to ₹67.10Cr in the Q2 2025-2026. On a quarterly growth basis, Syngene International Ltd has generated -22.61% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Syngene International Ltd Dividends April,2025

    In the quarter ending March 2025, Syngene International Ltd has declared dividend of ₹1.25 per share on 23 Apr 2025 - translating a dividend yield of 0.38%.

    Read More about Dividends

Indices Featuring Syngene Intl Stock

Check stock indices that include Syngene Intl .

BSE Healthcare

₹43,601.84

-0.61 (▲-268.92%)

S&P BSE 250 SmallCap

₹6,617.18

-0.5 (▲-33.18%)

Nifty Midcap 150

₹22,100.95

-0.4 (▲-89.8%)

S&P BSE 400 MidSmallCap

₹12,040.47

-0.46 (▲-56.12%)

Nifty 500

₹23,682.10

-0.41 (▲-98.15%)

Nifty Healthcare

₹14,607.90

-0.62 (▲-91.1%)

S&P BSE SmallCap Select

₹8,022.86

-0.49 (▲-39.47%)

Nifty LargeMidcap 250

₹16,723.40

-0.4 (▲-67.4%)

BSE 500

₹37,140.23

-0.41 (▲-154.44%)

Nifty MidSmallcap 400

₹20,046.45

-0.45 (▲-90.25%)

BSE Small-Cap

₹51,022.09

-0.58 (▲-296.59%)

Insights on Syngene International Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, SYNGENE stock has moved up by 1.4%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 892.2 Cr → 926.0 Cr (in ₹), with an average increase of 3.7% per quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 20.70% to 21.22% in Sep 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Take Solutions Ltd has given 137.9% return, outperforming this stock by 161.7%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 52.68% of holdings in Sep 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Vimta Labs Ltd has given 186.7% return, outperforming this stock by 173.4%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 6.45% to 6.08% in Sep 2025 quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 183.3 Cr → 67.1 Cr (in ₹), with an average decrease of 37.7% per quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 16.50% to 16.31% in Sep 2025 quarter

Syngene Intl Stock Futures & Options Contracts

View the latest movement in Syngene Intl Futures & Options, including strike prices, expiry dates, and percentage changes.

Syngene Intl Options

Name
Expiry
Strike Price
LTP
Absolute Change
Change
SYNGENE 30 Dec ₹660 Call
December 30, 2025
₹660
₹1.35
-0.75
-35.71%
SYNGENE 27 Jan ₹700 Call
January 27, 2026
₹700
₹5.7
-0.45
-7.32%
SYNGENE 27 Jan ₹660 Call
January 27, 2026
₹660
₹17.6
-0.95
-5.12%
SYNGENE 30 Dec ₹670 Call
December 30, 2025
₹670
₹0.2
-0.5
-71.43%

Syngene Intl Futures

Name
Expiry
Strike Price
LTP
Absolute Change
Change
SYNGENE 30 Dec Fut
December 30, 2025
-
₹652.25
-1.37
-0.21%
SYNGENE 27 Jan Fut
January 27, 2026
-
₹655.55
-2.37
-0.36%
SYNGENE 24 Feb Fut
February 24, 2026
-
₹661.75
-0.13
-0.02%

About Syngene International Ltd

Syngene International Limited is a India-based research, development, and manufacturing services organization driven by a team of 5200 scientists. It focuses primarily on the pharmaceutical and biotechnology sectors, and also provides services for nutrition, animal health, consumer goods, and other chemical sectors. The company’s health-related services extends across all major therapy areas and modalities. The operations are spread across 2 million sq. ft. with facilities at Bangalore, Hyderabad, and Mangalore. Syngene International Limited was incorporated in 1993 and consistently has entered into partnerships for research and development. This helped Syngene International cross an annual turnover of Rs 1000 crore in the year 2016. Over the years leading up to 2021, Syngene International expanded its research collaboration with companies such as Abbott, Bristol Myers Squibb, Herbalife, and Glaxo Smith Kline. It also commissioned new facilities and added bioreactors and microbial manufacturing capacity to strengthen biologics manufacturing. With investments in R&D and strengthening scientific capabilities, Syngene International continues to provide integrated drug discovery services.

Revenue: ₹910.60Cr as on September 2025 (Q2 FY26)
Net Profit: ₹67.10Cr as on September 2025 (Q2 FY26)
Listing date: 11 Aug, 2015
Chairperson Name: Kiran Mazumdar Shaw
OrganisationSyngene International Ltd
IndustryHealthcare
CEOKiran Mazumdar Shaw
E-voting on sharesClick here to vote

FAQs

What is Syngene Intl share price today?

Syngene Intl share price today stands at ₹655.55 as on at the close of the market. Syngene Intl share today touched a day high of ₹659.45 and a low of ₹651.3.

What is the 52 week high and 52 week low range for Syngene Intl share?

Syngene Intl touched a 52 week high of ₹895.75 and a 52 week low of ₹599.55. Syngene Intl share price today i.e. is closed at ₹655.55, which is -26.82% down from its 52 week high and 9.34% up from its 52 week low.

What is Syngene Intl 's market capitalisation today?

Syngene Intl market capitalisation is ₹26,378.43 Cr as on .

How to buy Syngene Intl shares?

To buy Syngene Intl shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for SYNGENE or Syngene International Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Syngene Intl shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Syngene Intl trading volume today?

Syngene Intl trading volume is 4.95L as on . This means that 4.95L shares of Syngene Intl were bought and sold on the stock market during today's trading session.